***Background.*** Long-term care facility (LTCF) residents are at higher risk for developing *Clostridium difficile*infections (CDI). Both Minnesota (MN) and New Mexico (NM) perform active population-based surveillance for CDI in select counties. While both states have historically similar overall CDI incidence rates, the proportion of LTCF-onset CDI is much higher in NM. We compared surveillance data from the two states to identify differences.

***Methods.*** We analyzed population-based CDI data from January 1, 2011-- September 30, 2013. A CDI case was defined as a stool specimen positive for *C. difficile* obtained from a patient without a *C. difficile*-positive specimen in the previous 8 weeks. A CDI case was classified as LTCF-onset if positive stool specimen was collected in a LTCF or within 3 days after hospital admission from a LTCF. A medical record review was performed on all LTCF-onset CDI cases in MN and a 10% random sample in NM. LTCF utilization data was obtained from the 2012 Area Resource File. Chi-square test was used for comparisons across the two states.

***Results.*** A total of 1597 and 3289 CDI cases were identified in MN and NM, respectively. Among all CDI cases, MN cases were less likely to be LTCF-onset (6% vs 26%; p \< 0.0001). Among cases with full review, no differences were detected between MN and NM in mean age (80 vs 77 years; p = 0.1), recent H2 receptor antagonist (18% vs 22%; p = 0.6), proton pump inhibiter (53% vs 48%; p = 0.6), or antibiotic usage (71% vs 77%; p = 0.4) in the 12 weeks prior to stool collection. MN LTCF-onset cases were more likely to have a positive test as a hospital inpatient (34% vs 18%; p = 0.02). Among persons greater than 65 years, LTCF utilization was higher in MN than NM (5.7% vs 2.9%, p \< 0.0001) and MN had significantly higher population rate of LTCFs (47 vs 25 per 100,000 persons; p \< 0.0001) and LTCF beds (2235 vs 2832 per 100,000 persons; p \< 0.0001).

***Conclusion.*** Despite LTCF utilization being higher in MN, this state had a lower proportion of LTCF-onset CDI cases compared to NM. No differences in age or prior use of antibiotics or acid reducing medications were detected between LTCF-onset cases in the two states. Further exploration of the variability in testing and infection control practices in LTCFs is warranted to identify prevention strategies directed to this patient population.
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